Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
A Risk Profile Using Simple Hematologic Parameters to Assess Benefits From Baricitinib in Patients Hospitalized With COVID-19: A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-2.
Journal: Annals of internal medicine
Published: February 26, 2024
Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case.
Journal: Open forum infectious diseases
Published: February 28, 2023
Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial.
Journal: Annals of internal medicine
Published: November 28, 2022
Anorectal Testing for Mpox Virus Infection in Men Who Have Sex With Men With and Without Proctitis.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: August 25, 2022
Week 96 Genotypic and Phenotypic Results of the Fostemsavir Phase 3 BRIGHTE Study in Heavily Treatment-Experienced Adults Living with Multidrug-Resistant HIV-1.
Journal: Antimicrobial agents and chemotherapy
Published: May 03, 2022
Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial.
Journal: The Lancet. Respiratory medicine
Published: December 01, 2021
Remdesivir for the Prevention of Invasive Mechanical Ventilation or Death in Coronavirus Disease 2019 (COVID-19): A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-1 Cohort Data.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: August 09, 2021
Patient-Reported Outcomes in the Phase III BRIGHTE Trial of the HIV-1 Attachment Inhibitor Prodrug Fostemsavir in Heavily Treatment-Experienced Individuals.
Journal: The patient
Published: June 07, 2021
Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial.
Journal: The Lancet. Respiratory medicine
Published: May 20, 2021
Abstinence-reinforcing contingency management improves HIV viral load suppression among HIV-infected people who use drugs: A randomized controlled trial.
Journal: Drug and alcohol dependence
Published: December 06, 2019
HIV Modifies the Effect of Tobacco Smoking on Oral Human Papillomavirus Infection.
Journal: The Journal of infectious diseases
Published: November 22, 2019
Last Updated: 09/26/2026